Krynica Vitamin (WAR:KVT) Operating Income: zł23.5 Mil (TTM As of Mar. 2026)


WAR:KVT Krynica Vitamin SA WAR:KVT
70 GF Score
Price zł12.80
GF Value zł10.40
Valuation Modestly Overvalued
! 8 Warning Signs
View Full Analysis

What is Krynica Vitamin Operating Income?

Krynica Vitamin WAR:KVT -2.66% 70 Operating Income is zł23.5 Mil as of Mar. 2026. GuruFocus rates WAR:KVT with a GF Score™ of 70/100 and a GF Value™ of zł10.40 (Modestly Overvalued). The stock has 8 warning signs investors should review.

Krynica Vitamin's Operating Income for the three months ended in Mar. 2026 was zł3.2 Mil. Its Operating Income for the trailing twelve months (TTM) ended in Mar. 2026 was zł23.5 Mil.

Operating Margin % is calculated as Operating Income divided by its Revenue. Krynica Vitamin's Operating Income for the three months ended in Mar. 2026 was zł3.2 Mil. Krynica Vitamin's Revenue for the three months ended in Mar. 2026 was zł85.3 Mil. Therefore, Krynica Vitamin's Operating Margin % for the quarter that ended in Mar. 2026 was 3.72%.

Warning Sign:

Krynica Vitamin SA operating margin has been in a 5-year decline. The average rate of decline per year is -18.4%.

Krynica Vitamin's 5-Year average Growth Rate for Operating Margin % was -18.40% per year.

Operating Income or EBIT is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Krynica Vitamin's annualized ROC % for the quarter that ended in Mar. 2026 was 8.04%. Krynica Vitamin's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was 3.09%.


Krynica Vitamin  (WAR:KVT) Operating Income Explanation

1. Operating Income or EBIT is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Krynica Vitamin's annualized ROC % for the quarter that ended in Mar. 2026 is calculated as:

ROC % (Q: Mar. 2026 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Dec. 2025 ) + Invested Capital (Q: Mar. 2026 ))/ count )
=12.704 * ( 1 - 0% )/( (152.016 + 163.922)/ 2 )
=12.704/157.969
=8.04 %

where

Note: The Operating Income data used here is four times the quarterly (Mar. 2026) data.

2. Joel Greenblatt's definition of Return on Capital:

Krynica Vitamin's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 is calculated as:

ROC (Joel Greenblatt) %(Q: Mar. 2026 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Dec. 2025  Q: Mar. 2026
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=3.892/( ( (115.063 + max(14.106, 0)) + (117.562 + max(5.249, 0)) )/ 2 )
=3.892/( ( 129.169 + 122.811 )/ 2 )
=3.892/125.99
=3.09 %

where Working Capital is:

Working Capital(Q: Dec. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(32.721 + 29.021 + 2.432) - (36.033 + 0 + 14.035)
=14.106

Working Capital(Q: Mar. 2026 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(46.873 + 43.377 + 2.353) - (66.957 + 0 + 20.397)
=5.249

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

3. Operating Income is also linked to Operating Margin %:

Krynica Vitamin's Operating Margin % for the quarter that ended in Mar. 2026 is calculated as:

Operating Margin %=Operating Income (Q: Mar. 2026 )/Revenue (Q: Mar. 2026 )
=3.176/85.348
=3.72 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

4. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Operating Income growth rate using Operating Income per share data.


Be Aware

Compared with a company's EBITDA margin, Operating Margin can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).

If a company is facing competition, its Operating Margin may decline. Often the Operating Margin declines well before the company's revenue or even profit decline. Therefore, Operating Margin is a very important indicator of whether the company is facing problems.

For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokia's Operating Margin had already been in decline since 2002, although its earnings per share were still rising. Investors who paid attention to Operating Margin would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).

Therefore, Operating Margin is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.


Krynica Vitamin Operating Income Related Terms


Krynica Vitamin Operating Income Historical Data

* Premium members only.

The historical data trend for Krynica Vitamin's Operating Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Krynica Vitamin Operating Income Chart

Krynica Vitamin Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Operating Income
Get a 7-Day Free Trial Premium Member Only Premium Member Only 23.39 20.88 8.61 17.71 20.88

Krynica Vitamin Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Operating Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.56 11.41 7.82 1.10 3.18
WAR:KVT
70GF Score
Krynica Vitamin SA WAR:KVT
Operating Income is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Krynica Vitamin Operating Income Calculation

Operating Income, is the profit a company earned through operations. All expenses, including cash expenses such as cost of goods sold (COGS), research & development, wages, and non-cash expenses, such as depreciation, depletion and amortization, have been deducted from the sales.

Operating Income for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was zł23.5 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Operating Income →
What does a Operating Income of zł23.5 Mil mean?
Krynica Vitamin (WAR:KVT) has a Operating Income of zł23.5 Mil as of Mar. 2026. Operating Income equals sales less all operating expenses. It is linked to EBIT. View historical data on Krynica Vitamin and its competitors.
Is Krynica Vitamin's Operating Income too high?
Krynica Vitamin's current Operating Income is zł23.5 Mil. Overall, Krynica Vitamin has a GF Score™ of 70/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Krynica Vitamin's Operating Income compare to KO and PEP?
Krynica Vitamin's Operating Income of zł23.5 Mil can be compared against companies in the Beverages - Non-Alcoholic industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Operating Income for a Beverages - Non-Alcoholic company?
A good Operating Income depends on the Beverages - Non-Alcoholic industry context. However, Operating Income should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Operating Income mean?
A high Operating Income can signal that a stock is expensive relative to its fundamentals. Operating Income equals sales less all operating expenses. It is linked to EBIT. View historical data on Krynica Vitamin and its competitors. Krynica Vitamin's current Operating Income is zł23.5 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Krynica Vitamin stock overvalued right now?
Based on GuruFocus' analysis, Krynica Vitamin (WAR:KVT) is currently considered Modestly Overvalued. The stock's GF Value™ is zł10.40, compared to a current price of zł12.80 — trading 23.1% above its estimated fair value. The current Operating Income is zł23.5 Mil. Krynica Vitamin's overall GF Score™ is 70/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Operating Income calculated?
Operating Income is calculated from a company's financial statements. For Krynica Vitamin (WAR:KVT), the current Operating Income is zł23.5 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Krynica Vitamin (WAR:KVT) Overvalued in 2026?

Based on GuruFocus' analysis, Krynica Vitamin stock appears to be overvalued. The current stock price of zł12.80 is trading 23.1% above its estimated GF Value™ of zł10.40. GuruFocus considers Krynica Vitamin to be Modestly Overvalued.

Key valuation signals for WAR:KVT:

  • Operating Income: zł23.5 Mil
  • GF Value™: zł10.40 vs. price of zł12.80 (23.1% above fair value)
  • GF Score™: 70/100 with 8 warning signs

No single metric tells the full story. See the WAR:KVT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Krynica Vitamin Business Description

Address Ulica Matyldy 35, Warsaw, POL, 03-606
Krynica Vitamin SA is a Polish producer of non-alcoholic and low-alcoholic beverages. The company is engaged in producing beverages for own brands and providing bottling services for brand-name products. It offer includes functional and energy drinks such as isotonic and hypotonic drinks, beverages that support metabolism, and diet supplementary vitamin drinks. It also offers functional waters, modern mixed-fruit drinks, drinks with fruit pulp, alcopops, ciders, malt beverages and a wide selection of carbonated beverages.
70GF Score

Get the complete analysis for WAR:KVT

Operating Income is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

zł12.80
Price
zł10.40
GF Value